Rick Conzemius

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Is Carbapenem Therapy Necessary for the Treatment of Non-CTX-M Extended-Spectrum β-Lactamase-Producing Enterobacterales Bloodstream Infections?”.

Is Carbapenem Therapy Necessary for the Treatment of Non-CTX-M Extended-Spectrum β-Lactamase-Producing Enterobacterales Bloodstream Infections?

Clinical Infectious Diseases(2023)10.1093/cid/ciad703

N/A

0.345DataRank · unranked

9 citations

Sara E. Cosgrove, Patricia J. Simner, Anthony Harris, Yehudit Bergman, Rick Conzemius +4 more

Molecular epidemiology of β-lactamases in ceftriaxone-resistant Enterobacterales bloodstream infections in the mid-Atlantic United States

Antimicrobial Agents and Chemotherapy(2025)10.1128/aac.01258-24

N/A

0.345DataRank · unranked

9 citations

Yehudit Bergman, Emily Jacobs, Jennifer Lu, Nancy D. Hanson, Rick Conzemius +5 more

An NDM-Producing Escherichia coli Clinical Isolate Exhibiting Resistance to Cefiderocol and the Combination of Ceftazidime-Avibactam and Aztreonam: Another Step Toward Pan-β-Lactam Resistance

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad276

N/A

0DataRank · unranked

67 citations

Yehudit Bergman, Rick Conzemius, Emily Jacobs, Tsigereda Tekle, Stephan Beisken +2 more

Successful Treatment of Carbapenem-Resistant Acinetobacter baumannii Meningitis With Sulbactam-Durlobactam

Clinical Infectious Diseases(2024)10.1093/cid/ciae210

N/A

0DataRank · unranked

21 citations

Shanan Immel, Sara M. Karaba, Caitlin Soto, Rick Conzemius, Emily Gisriel +6 more